| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/30/2007 | US7169585 Papillomavirus vaccine |
| 01/30/2007 | US7169397 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
| 01/30/2007 | US7169395 combining a mixture of RSV proteins with non-virulent influenza virus in a vaccine formulation provides an immune response which is substantially the same as the response obtained by administration of the components individually |
| 01/30/2007 | CA1341520C Peptides capable of binding hiv (human immunodeficiency virus) antibodies, their use in diagnosis hiv infections, or for aids vaccination |
| 01/25/2007 | WO2007011210A2 Parechovirus, vaccines, medicaments and diagnostic kits |
| 01/25/2007 | WO2007010398A2 Caveolin-3 and in vitro culture of hepatitis c virus |
| 01/25/2007 | WO2007010028A1 Cell line for producing coronaviruses |
| 01/25/2007 | WO2007009673A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 01/25/2007 | US20070021593 for use in the treatment of inflammation and ischemia-reperfusion injury |
| 01/25/2007 | US20070020760 Medium supplement and animal cell culture medium |
| 01/25/2007 | US20070020240 Defined dose therapeutic phage |
| 01/25/2007 | US20070020238 Method of targeted gene delivery using viral vectors |
| 01/25/2007 | CA2615558A1 Caveolin-3 and in vitro culture of hepatitis c virus |
| 01/25/2007 | CA2615468A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 01/25/2007 | CA2614322A1 Paramyxoviridae virus preparations |
| 01/24/2007 | EP1746102A1 Parechovirus, vaccines, medicaments and diagnostic kits |
| 01/24/2007 | EP1383795B1 A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 01/24/2007 | EP1238092B1 Bovine immunodeficiency virus (biv) based vectors |
| 01/24/2007 | EP0760000B1 Alphavirus expression vector |
| 01/24/2007 | CN1902308A Method of producing baculovirus |
| 01/24/2007 | CN1900320A Diagnostic assay |
| 01/23/2007 | US7166426 utilizing a first isolated antigen derived from a region of the hepatitis C virus polyprotein and a multiple epitope fusion antigen; for accurately diagnosing hepatitis C virus infection; solid phase synthesis |
| 01/23/2007 | CA2208928C Selective stabilization of protein during viral inactivation |
| 01/18/2007 | WO2007007055A1 Bacteriophage and their uses |
| 01/18/2007 | WO2004087047A3 Mutants of replication competent vaccinia virus |
| 01/18/2007 | US20070015238 Production of pseudotyped recombinant AAV virions |
| 01/18/2007 | US20070015203 Infectious bovine viral diarrhea virus |
| 01/18/2007 | US20070014810 Epitope based vaccines directed towards HPV; side effect reduction; vaccination |
| 01/18/2007 | US20070014770 Bacteriophage and their uses |
| 01/18/2007 | US20070014769 Adenovirus vectors comprising meganuclease-type endonucleases, and related systems |
| 01/18/2007 | CA2614800A1 Bacteriophage specifically for lysing propionibacterium acnes and uses thereof |
| 01/17/2007 | EP1743942A1 Recombinant virus vector for gene introduction in lymphocyte |
| 01/17/2007 | EP1743041A1 Modified viral vector particles |
| 01/17/2007 | EP1742963A2 Synthesis and purification of west nile virus virus-like particles |
| 01/17/2007 | EP1742658A2 Cellular permissivity factor for viruses, and uses thereof |
| 01/17/2007 | EP1742657A2 Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1086207B1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 01/17/2007 | CN1898379A Methods for producing cell lines stable in serum-free medium suspension culture |
| 01/17/2007 | CN1895667A Reovirus inactivated vaccine and its preparation |
| 01/17/2007 | CN1295339C Attenuated vaccinia virus Tiantan strain vector and its preparation and application |
| 01/17/2007 | CN1295325C Virus lysis method |
| 01/16/2007 | US7163818 Especially having a plurality of different K specific hydrolytic tail proteins. |
| 01/11/2007 | WO2007006031A2 Method for the preparation of prrs virus and proteins of and diagnostic test kits for detecting them |
| 01/11/2007 | WO2007003612A1 Tumor restricted oncolytic virus with improved cell transduction spectrum |
| 01/11/2007 | WO2007003229A1 Tumor restricted oncolytic virus with improved cell transduction spectrum |
| 01/11/2007 | WO2006110589A3 Gammaretrovirus associated with cancer |
| 01/11/2007 | US20070010017 Lentiviral packaging constructs |
| 01/11/2007 | US20070010016 Gene transfer with adenoviruses having modified fiber proteins |
| 01/11/2007 | US20070010015 Complete empty viral particles of infectious bursal disease virus (ibdv), production method thereof and applications of same |
| 01/11/2007 | US20070010001 Improved bacteriophage compositions comprising specific sugars that reduce or abolish the bacterial phage-neutralizing activity; used to treat infectious diseases |
| 01/11/2007 | US20070009949 Paramyxovirus-derived RNP |
| 01/11/2007 | US20070009552 Simultaneous protection against each of the four dengue viruses, thereby precluding the possibility of developing the more serious illnesses dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS), which occur in humans during secondary infection with a heterotypic wild-type dengue virus |
| 01/11/2007 | US20070009550 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/11/2007 | US20070009548 Inactivated chimeric and related methods of use |
| 01/11/2007 | CA2656741A1 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites |
| 01/11/2007 | CA2614332A1 Method for the preparation of prrs virus and proteins of and diagnostic test kits for detecting them |
| 01/10/2007 | EP1741789A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 01/10/2007 | EP1741785A1 Porcine circoviruses, nucleic acids, polypeptides and vaccines |
| 01/10/2007 | EP1741777A1 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/10/2007 | EP1741720A1 Modified DNA molecule, recombinant containing the same, and uses thereof |
| 01/10/2007 | EP0934423B1 Aav-dna helper virus sequences |
| 01/10/2007 | CN1894400A Serum-free VERO cell banking process |
| 01/10/2007 | CN1893973A Methods for porducing storage stable viruses and immunogenic compositions thereof |
| 01/10/2007 | CN1891829A Alpha (1,3) galactosyl transferase recombinant vector, virosome and its preparation and use |
| 01/09/2007 | US7161057 Transgenic animal; urokinase plasminogen activator; viricides; detecting liver toxicity |
| 01/09/2007 | US7160721 Cell culture for use treatment of viral diseases |
| 01/09/2007 | US7160549 including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter |
| 01/09/2007 | US7160464 Methods for removal, purification, and concentration of viruses and methods of therapy based thereupon |
| 01/09/2007 | CA2327107C Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same |
| 01/09/2007 | CA2203885C Treating red blood cell solutions with anti-viral agents |
| 01/04/2007 | WO2007002470A2 Inactivated chimeric vaccines and related methods of use |
| 01/04/2007 | WO2006077020A3 Method for the specific or unspecific separation of cells and/or viruses from aqueous media and use thereof |
| 01/04/2007 | WO2005112994A8 Nodavirus-vlp immunization composition |
| 01/04/2007 | WO2005028634A3 Improved mva vaccines |
| 01/04/2007 | US20070004042 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 01/04/2007 | US20070003923 Modified fiber proteins for efficient receptor binding |
| 01/04/2007 | US20070003574 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
| 01/04/2007 | US20070003573 Viral expression vector for use in the treatment and diagnosis of viral, cardiovascular, nervous system and metabolic disorders |
| 01/04/2007 | US20070003571 Modified herpes simplex viral particle for targeting and destroying tumor cells |
| 01/04/2007 | US20070003520 Mutant viruses |
| 01/04/2007 | CA2613284A1 Methods and compositions for expressing negative-sense viral rna in canine cells |
| 01/04/2007 | CA2609142A1 Therapeutic gene vectors comprising mirna target sequences |
| 01/03/2007 | EP1739167A1 Method of producing virus |
| 01/03/2007 | EP1267920B1 Compositions comprising cold-adapted equine influenza viruses for the treatment of existing viral infections of the respiratory system. |
| 01/03/2007 | EP0929315B1 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 01/03/2007 | EP0776361B1 Recombinant herpesvirus of turkeys and uses thereof |
| 01/03/2007 | CN1890366A Isolated phages and their use as disinfectant in food or for sanitation of factory environment |
| 01/03/2007 | CN1890257A Virus filtration of liquid factor vii compositions |
| 01/03/2007 | CN1293195C Reverse genetic operation system of New castle disease LaSota vaccine strain and its applciation |
| 01/02/2007 | US7157266 Structure of adenovirus bound to cellular receptor car |
| 01/02/2007 | US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
| 01/02/2007 | US7157083 Aid therapy |
| 01/02/2007 | CA2311336C Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same |
| 01/02/2007 | CA2237059C Targeted adenovirus vectors |
| 12/28/2006 | WO2006136704A2 Cdna construct of salmonidae alphavirus |
| 12/28/2006 | WO2006136566A1 Process for the preparative purification of virus-like particles (vlps) |
| 12/28/2006 | WO2006136448A2 Attenuated sars and use as a vaccine |
| 12/28/2006 | WO2006091511A3 Primate t-lymphotropic viruses |
| 12/28/2006 | US20060292682 Addition of transgenes into adenoviral vectors |